Iloprost

Generic Name
Iloprost
Brand Names
Ventavis
Drug Type
Small Molecule
Chemical Formula
C22H32O4
CAS Number
78919-13-8
Unique Ingredient Identifier
JED5K35YGL
Background

Iloprost is a synthetic analogue of prostacyclin PGI2 that dilates systemic and pulmonary arterial vascular beds. It is used to treat pulmonary arterial hypertension (PAH).

Indication

Used for the treatment of pulmonary arterial hypertension.

Associated Conditions
NYHA class III Pulmonary arterial hypertension, NYHA class IV Pulmonary arterial hypertension
Associated Therapies
-
Clinical Trials
Related News

Treatment of Elevated Arterial Pulmonary Pressure With Inhaled Iloprost

First Posted Date
2005-09-22
Last Posted Date
2009-02-04
Lead Sponsor
Lund University Hospital
Target Recruit Count
40
Registration Number
NCT00216931
Locations
🇸🇪

University Hospital in Lund , Department of Pediatrics, Lund, Sweden

Iloprost in Preventing Lung Cancer in Patients at High Risk for This Disease

First Posted Date
2004-06-11
Last Posted Date
2020-05-14
Lead Sponsor
University of Colorado, Denver
Target Recruit Count
152
Registration Number
NCT00084409
Locations
🇺🇸

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

🇺🇸

Mayo Clinic Cancer Center, Rochester, Minnesota, United States

🇺🇸

University of Colorado Cancer Center at UC Health Sciences Center, Aurora, Colorado, United States

and more 3 locations

Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Iloprost for Raynaud's Phenomenon Secondary to Systemic Sclerosis

Phase 3
Completed
Conditions
Systemic Sclerosis
Raynaud Disease
First Posted Date
2000-02-25
Last Posted Date
2005-06-24
Lead Sponsor
National Center for Research Resources (NCRR)
Target Recruit Count
200
Registration Number
NCT00004786
© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy